During checkout, this product may be reported as "Out of Stock" with an Estimated Availability date. The Actual Availability date for this product may be earlier. Send inquiries regarding Actual Availability date, including the catalog number, to discoverysciences@lifetech.com.
Thermo Scientific™

CellSensor™ T-REx™ NICD CSL-bla HeLa Cell Line

Catalog number:  K1487

Related applications:

Pharma & Biopharma

Back to top


The CellSensor® T-REx™ NICD CSL-bla HeLa cell line was engineered by lentiviral transduction of HeLa cervical cancer cells with a notchresponse element driving beta-lactamase reporter gene expression (CSL-bla) along with tetracycline repressor and tetracycline (or the tetracycline analog, doxycycline)-inducible NICD (notch intracellular domain) constructs. This cell line is a clonal population isolated by flow cytometry. Addition of doxycycline to these cells allows for regulated NICD transcription factor expression and subsequent beta-lactamase expression. This cell line has been tested for robust assay performance by assessing a variety of parameters, including cell plating number, DMSO tolerance, stimulation time, and substrate loading time. Assay validation was performed using serial dilutions of doxycycline. Additional testing data using RNAi and alternate stimuli are also available.
For Research Use Only. Not for use in diagnostic procedures.


Assay Entry: Cell-based beta lactamase reporter gene
Cell Line: HeLa
Cell State: Dividing Cells
Detection Method: Fluorescent
Druggable Target: Signaling Pathway
Product Line: CellSensor™, T-REx™
System Type: CellSensor™
Target Entry: NICD, Notch pathway

Contents & storage

CellSensor® T-REx™ NICD CSL-bla HeLa cells are shipped on dry ice. Store in liquid nitrogen immediately upon receipt, or thaw for immediate use.